Cystic Fibrosis Australia (CFA) is the peak consumer body for people living with cystic fibrosis (CF).
We focus on collaborative programmes and research, funding partnerships and advocacy.
CF is a recessive genetic condition. It primarily affects the lungs and digestive system because of a malfunction in the exocrine system, responsible for producing saliva, sweat, tears and mucus
Get Involved
By supporting CFA you will be helping further research, development, collaboration and advocacy so that all Australians living with CF are represented at a national level and heard by Government and Health and Community sectors.
Numbers Speak
CF is a genetic condition, however, each person with CF is unique.
Over
There are over
Average life expectancy
A baby is born with CF every
CF Research
CFA leads the national research program, the Australian Cystic Fibrosis Research Trust (ACFRT), by overseeing all administration requirements. The ACFRT is dedicated to the core objective of funding research into the treatment and cure of CF.
It is important to note that 100% of the funds raised or donated to the ACFRT are used to support research.
Standards of Care
The first four chapters of the Standards of Care For Cystic Fibrosis have been published, with more to be added in the coming months.
2025 Annual Report
Our 2025 Annual Report is now live.
This year marked a turning point for the cystic fibrosis community — with expanded treatment access, stronger national advocacy, and continued progress toward longer, healthier lives. Explore the milestones and the people behind the impact.
Need More Information?
If you have any questions, need more information, or would like to sign up to our regular newsletters, please contact us.